GCM
AGN

Glenview Capital Management’s Allergan plc AGN Stock Holding History

Glenview Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-374,710
Closed -$71.6M – 58
2019
Q4 		$71.6M Buy
374,710
+220,310
+143% +$39.7M 0.63% 36
2019
Q3 		$26M Buy
+154,400
New +$25.2M 0.27% 43
2019
Q1 		– Sell
-200,971
Closed -$26.9M – 58
2018
Q4 		$26.9M Sell
200,971
-1,462,833
-88% -$240M 0.26% 45
2018
Q3 		$317M Sell
1,663,804
-108,677
-6% -$20M 2.01% 22
2018
Q2 		$296M Buy
1,772,481
+245,591
+16% +$39.4M 2.02% 21
2018
Q1 		$257M Buy
1,526,890
+372,314
+32% +$62.4M 1.5% 29
2017
Q4 		$189M Buy
+1,154,576
New +$207M 1.02% 29
2015
Q4 		– Sell
-1,523,609
Closed -$414M – 78
2015
Q3 		$414M Sell
1,523,609
-459,100
-23% -$141M 2.06% 20
2015
Q2 		$602M Hold
1,982,709
– – 2.38% 13
2015
Q1 		$590M Buy
1,982,709
+140,840
+8% +$40.2M 2.69% 10
2014
Q4 		$474M Buy
1,841,869
+124,011
+7% +$31M 2.37% 11
2014
Q3 		$414M Buy
+1,717,858
New +$384M 2.17% 14

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Glenview Capital Management's AGN Position: Q1 2020 in Review

Glenview Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 374,710 shares — an estimated $71.6M sold.

Glenview Capital Management first reported a position in AGN in Q3 2014 and held it in 12 quarters. The position peaked at $602M in Q2 2015. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Glenview Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Glenview Capital Management sold 374,710 Allergan plc shares in Q1 2020, an estimated $71.6M.
  • Glenview Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 12 quarters.
  • Glenview Capital Management's Allergan plc position peaked at $602M in Q2 2015.
  • 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Glenview Capital Management's 13F filing for Q1 2020, filed 15 May 2020.